College-educated women ages 25–55 who spent years getting dismissed by conventional doctors are now self-directing their own SIBO and gut recovery protocols through stacked supplements, at-home breath tests, and functional medicine telehealth. Their core goal is getting their daily life back after years of debilitating bloating, pain, and misdiagnosis — not wellness optimization.
The global gut health supplement market is valued at $16B in 2026 and growing at 7.9–8.9% CAGR, meaning new buyers are entering continuously and each relapse cycle restarts spending — driving compounding annual revenue for any product in this stack. (Grand View Research / Persistence Market Research, April 2026: https://www.prnewswire.com/news-releases/gut-health-supplement-market-to-reach-us-29-1-billion-by-2033-expands-amid-rising-preventive-healthcare-adoption-and-nutraceutical-innovation-302738400.html)
SIBO recurrence rates hit 40–60% within 9–12 months of treatment, meaning nearly half of all treated patients re-enter the buying cycle within a year — making this a chronic-repeat-purchase market, not a one-time fix. (Dignity Integrative, July 2025: https://www.dignityintegrative.com/post/how-often-does-sibo-recur)
A 2025 study found that GLP-1 receptor agonist users are diagnosed with SIBO about twice as often as those on other diabetes medications, adding a fast-growing new patient cohort who are already active supplement buyers seeking gut relief. (Trio-Smart / Damianos et al., 2025: https://www.triosmartbreath.com/glp-1-and-sibo)
The exact words they type into Google.
Create a free account to unlock the full breakdown — all 3 ideas and every community map on the site.
Free forever. No credit card. Takes 20 seconds.